• Call +1.858.633.0165 or Fax +1.858.633.0166 or Contact Us

Etalocib Inhibitor

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS5756873

Etalocib, a novel diaryl ether carboxylic acid derivative, is a selective and potent inhibitor of the lipoxygenase pathway either via antagonism of the leukotriene B4 (LTB4) receptor or directly through 5'-lipoxygenase. LY293111 has antineoplastic activities. More details

Please Inquire
Product Documentation
PDF
Sample Manual Insert View PDF
PDF
Testing Data View PDF
PDF
Certificate of Analysis (COA) View PDF
PDF
QC Report View PDF
PDF
Material Safety Data Sheet View PDF
PDF
Technical Datasheet View PDF
PDF
Protocol View PDF

Product Overview

Online Datasheet in PDF
Product Name
Etalocib, Inhibitor
Full Product Name
Etalocib
Product Synonym Names
LY293111; VML295
Form/Format
Solid. Powder
Purity/Purification
98.00%
Preparation and Storage
Store at -20 degree C for 3 years powder
-80 degree C for 2 years in solvent
Molecular Weight
544.6
Solubility
<1mg/ml refers to the product slightly soluble or insoluble
Formula
C33H33FO6
CAS Number
161172-51-6
Target & IC50
Others

Other Notes

Small volumes of Etalocib, inhibitor vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

Searchable Terms for Etalocib purchase

MBS5756873 is an inhibitor targeting Etalocib.
Request a Quote

Please fill out the form below and our representative will get back to you shortly.

MBS000000
Contact Us

Please fill out the form below and our representative will get back to you shortly.

MBS000000